Evaluation of a fluorescence polarographic immunoassay with increased sensitivity for measurement of low concentrations of tobramycin in serum

Therapeutic Drug Monitoring

Volumn 18, Issue 2, 1996, Pages 189-193

  Touw, D J ^a   De Graaf, A I ^b   De Goede, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hague Hospitals Central Pharmacy   (Netherlands)

Author keywords

Analysis; Analytical validation; Assay; Fluorescence polarization immunoassay; Method; Tobramycin

Indexed keywords

AZTREONAM; CEFTAZIDIME; CILASTATIN; FLUCLOXACILLIN; GENTAMICIN; IMIPENEM; NETILMICIN; TOBRAMYCIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HYPERBILIRUBINEMIA; HYPERLIPIDEMIA; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANTI-BACTERIAL AGENTS; FLUORESCENCE POLARIZATION IMMUNOASSAY; SENSITIVITY AND SPECIFICITY; TOBRAMYCIN;

EID: 0029975040     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199604000-00013     Document Type: Article

References (3)

1. Whitehead AG, Grgurinovich N, Birkett DJ. Analysis of low theophylline concentrations using the Abbott TDx. Ther Drug Monit 1991;13:379-80.
2. Shah VP, Midha KK, Dighe S, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 1992;9:588-92.
3. Fraser CG. Desirable standards of performance for therapeutic drug monitoring. Clin Chem 1987;33:387-9.